(Q61785713)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009274%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

editorial

0 references

title

Conclusions from the VA-HIT study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009274%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

H B Rubins

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009274%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S J Robins

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009274%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009274%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009274%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009274%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009274%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

543-544

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009274%20AND%20SRC:MED&resulttype=core&format=json

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901010-9

High-density lipoprotein--the clinical implications of recent studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901010-9

The ABCs of cholesterol efflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901010-9

Getting a handle on "good" cholesterol with the high-density lipoprotein receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901010-9

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901010-9

Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901010-9

When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901010-9

Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901010-9

MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901010-9

The veterans affairs high-density lipoprotein intervention trial: Baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901010-9

Development of the multiple metabolic syndrome: an epidemiologic perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901010-9

Some coronary risk factors related to the insulin resistance syndrome and treatment with gemfibrozil. Experience from the Helsinki Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901010-9

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901010-9

10.1016/S0002-9149(00)01010-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009274%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference